355 related articles for article (PubMed ID: 34052423)
1. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis.
Tagliamento M; Agostinetto E; Bruzzone M; Ceppi M; Saini KS; de Azambuja E; Punie K; Westphalen CB; Morgan G; Pronzato P; Del Mastro L; Poggio F; Lambertini M
Crit Rev Oncol Hematol; 2021 Jul; 163():103365. PubMed ID: 34052423
[TBL] [Abstract][Full Text] [Related]
2. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis.
Khoury E; Nevitt S; Madsen WR; Turtle L; Davies G; Palmieri C
JAMA Netw Open; 2022 May; 5(5):e2210880. PubMed ID: 35532936
[TBL] [Abstract][Full Text] [Related]
3. Mortality in patients with cancer and SARS-CoV-2 infection: Results from the Argentinean Network of Hospital-Based Cancer Registries.
Fattore GL; Olivos NSA; Olalla JEC; Gomez L; Marucco AF; Mena MPR
Cancer Epidemiol; 2022 Aug; 79():102200. PubMed ID: 35772301
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.
Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A
Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.
Noori M; Azizi S; Abbasi Varaki F; Nejadghaderi SA; Bashash D
Int Immunopharmacol; 2022 Sep; 110():109046. PubMed ID: 35843148
[TBL] [Abstract][Full Text] [Related]
6. Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.
Lund LC; Rahbek MT; Brown P; Obel N; Hallas J; Frederiksen H
Eur J Haematol; 2023 Dec; 111(6):946-950. PubMed ID: 37740535
[TBL] [Abstract][Full Text] [Related]
7. Case fatality rate of COVID-19: a systematic review and meta-analysis.
Alimohamadi Y; Tola HH; Abbasi-Ghahramanloo A; Janani M; Sepandi M
J Prev Med Hyg; 2021 Jun; 62(2):E311-E320. PubMed ID: 34604571
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.
SeyedAlinaghi S; Karimi A; Mirzapour P; Salmani R; Razi A; Mojdeganlou H; Mojdeganlou P; Qodrati M; Jashaninejad R; Paranjkhoo P; Dadras O; Zarezadeh B; Afsahi AM; Afzalian A; Varshochi S; Mehraeen E; Afsahi G
Infect Disord Drug Targets; 2023; 23(7):29-38. PubMed ID: 37138433
[TBL] [Abstract][Full Text] [Related]
9. Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.
Martins-Branco D; Nader-Marta G; Tecic Vuger A; Debien V; Ameye L; Brandão M; Punie K; Loizidou A; Willard-Gallo K; Spilleboudt C; Awada A; Piccart M; de Azambuja E
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3075-3080. PubMed ID: 35867203
[TBL] [Abstract][Full Text] [Related]
10. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study.
Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z
Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157
[TBL] [Abstract][Full Text] [Related]
11. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Guven DC; Sahin TK; Akın S; Uckun FM
Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
Naimi A; Yashmi I; Jebeleh R; Imani Mofrad M; Azimian Abhar S; Jannesar Y; Heidary M; Pakzad R
J Clin Lab Anal; 2022 May; 36(5):e24387. PubMed ID: 35385130
[TBL] [Abstract][Full Text] [Related]
14. Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.
Carrara E; Razzaboni E; Azzini AM; De Rui ME; Pinho Guedes MN; Gorska A; Giannella M; Bussini L; Bartoletti M; Arbizzani F; Palacios-Baena ZR; Caponcello G; Maldonado N; Rodríguez-Baño J; Visco C; Krampera M; Tacconelli E
Hematol Oncol; 2023 Feb; 41(1):16-25. PubMed ID: 36238977
[TBL] [Abstract][Full Text] [Related]
15. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis.
Lim ZJ; Subramaniam A; Ponnapa Reddy M; Blecher G; Kadam U; Afroz A; Billah B; Ashwin S; Kubicki M; Bilotta F; Curtis JR; Rubulotta F
Am J Respir Crit Care Med; 2021 Jan; 203(1):54-66. PubMed ID: 33119402
[No Abstract] [Full Text] [Related]
16. Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients.
Di Felice G; Visci G; Teglia F; Angelini M; Boffetta P
Elife; 2022 Feb; 11():. PubMed ID: 35171096
[TBL] [Abstract][Full Text] [Related]
17. Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis.
Nopsopon T; Kittrakulrat J; Takkavatakarn K; Eiamsitrakoon T; Kanjanabuch T; Pongpirul K
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009156. PubMed ID: 34129609
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies.
Saini KS; Tagliamento M; Lambertini M; McNally R; Romano M; Leone M; Curigliano G; de Azambuja E
Eur J Cancer; 2020 Nov; 139():43-50. PubMed ID: 32971510
[TBL] [Abstract][Full Text] [Related]
19. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination.
Martín-Sánchez V; Ruiz-Garcia A; Vitelli-Storelli F; Serrano-Cumplido A; Barquilla-Garcia A; Micó-Pérez RM; Olmo-Quintana V; Calderón-Montero A; Segura-Fragoso A
Semergen; 2023 Oct; 49(7):102026. PubMed ID: 37356278
[TBL] [Abstract][Full Text] [Related]
20. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers.
Başcı S; Ata N; Altuntaş F; Yiğenoğlu TN; Dal MS; Korkmaz S; Namdaroğlu S; Baştürk A; Hacıbekiroğlu T; Doğu MH; Berber İ; Dal K; Erkurt MA; Turgut B; Çelik O; Ülgü MM; Birinci Ş;
Intern Emerg Med; 2022 Jan; 17(1):135-139. PubMed ID: 34110562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
